(6R,7R)-3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, sodium salt;(6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt; Anaptivan; Biociclin; Biofurex; Cefurin; Duxima; Novocef; Zinacef;Cefuroxime Sodium Salt;
Cefuroxime Axetil Impurity D Sodium Salt is a fully characterized chemical compound used as a reference standard of API Cefuroxime. The standard offered is compliant with regulatory guidelines. Cefuroxime Axetil Impurity D Sodium Salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 56238-63-2
Related products
Cefuroxime Sodium EP Impurity I (Methoxyiminofurylacetic Acid)
M.F.
M.W. 169.14
CAT# AR-C02187
CAS# 39684-61-2
